Literature DB >> 824226

Periosteal osteosarcoma. Review of 41 cases, 22 with long-term follow-up.

M Campanacci, A Giunti.   

Abstract

This study is based on 41 cases of parostesl (or juxta cortical) osteogenic sarcoma, which the authors prefer to define as periosteal osteosarcoma. The clinical features, radiological and histological characteristics are analysed. Treatment and prognosis are discussed. The treatment usually indicated is amputation, but in selected cases radical segmental resection is appropriate. The prognosis is comparatively favourable if the correct surgical treatment is carried out without delay.

Entities:  

Mesh:

Year:  1976        PMID: 824226

Source DB:  PubMed          Journal:  Ital J Orthop Traumatol        ISSN: 0390-5489


  5 in total

Review 1.  Periosteal osteosarcoma: a review of clinical evidence.

Authors:  Xin-Wei Liu; Ying Zi; Liang-Bi Xiang; Tian-Yu Han
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Ancient DNA confirmation of lepromatous leprosy in a skeleton with concurrent osteosarcoma, excavated from the leprosarium of St. Mary Magdalen in Winchester, Hants., UK.

Authors:  G Cole; G M Taylor; G R Stewart; H Dawson-Hobbis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-09-17       Impact factor: 5.103

3.  Reconstruction of bone defect with autograft fibula and retained part of tibia after marginal resection of periosteal osteosarcoma: a case report.

Authors:  Tongyu Hu; Wei Chen; Jianheng Li; Chenguang Du; Yingze Zhang
Journal:  World J Surg Oncol       Date:  2015-06-18       Impact factor: 2.754

4.  Periosteal Osteosarcoma: A Review of 17 Cases with Mean Follow-up of 52 Months.

Authors:  Matthew P Revell; Neeta Deshmukh; Robert J Grimer; Simon R Carter; Roger M Tillman
Journal:  Sarcoma       Date:  2002

5.  Periosteal Osteosarcoma: A Single-Institutional Study of Factors Related to Oncologic Outcomes.

Authors:  Chung Ming Chan; Adam D Lindsay; Andre R V Spiguel; C Parker Gibbs; Mark T Scarborough
Journal:  Sarcoma       Date:  2018-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.